New drugs for asthma therapy (agents and actions supplements, vol 34)

Whelan C.J.

首页> 外文期刊>FEBS Letters >New drugs for asthma therapy (agents and actions supplements, vol 34)

【24h】

New drugs for asthma therapy (agents and actions supplements, vol 34)

机译：哮喘治疗新药（药物和作用补品，第34卷）

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《FEBS Letters》 |1992年第1期|共页
作者
Whelan C.J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类分子生物学;
关键词

相似文献

外文文献
中文文献
专利

1. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Supplemental Actions Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2011,第9期

机译：当前与FDA有关的药物信息由FDA批准的新药物新剂型和适应症，由FDA代理商批准的待批FDA批准的新药/生物许可申请，由制造商提出的补充措施，由制造商提出的重要措施，或与“亲爱的健康专业人员”的信件有关安全
2. New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Supplemental Actions Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2011,第11期

机译：FDA批准的新药FDA批准前的FDA代理人批准的新剂型和适应症制造商提出的新药/生物许可申请由制造商提出的补充措施重大标签变更或与安全相关的“亲爱的健康专业人员”信函
3. A STUDY ON ADVERSE DRUG REACTIONS AND THEIR RISK FACTORS OF ANTI- ASTHMATIC AGENTS AMONG GARMENTS DUST-INDUCED ASTHMATIC PATIENTS IN MANCHESTER OF SOUTH INDIA [J] . Muthukumar A, Sundara Ganapathy R Asian Journal of Pharmaceutical and Clinical Research . 2018,第9期

机译：印度南部曼彻斯特服装成尘哮喘病患者中抗哮喘药物的不良药物反应及其危险因素的研究
4. PM-TOM: A Method for Finding Personalized Polypharmacy Therapies with Minimal Adverse Drug-Drug, Drug-Gene and Drug-Condition Interactions [C] . Adnan Kulenovic, Azra Lagumdzija-Kulenovic Medical Informatics Europe Conference . 2020

机译：PM-TOM：一种以最小的不良药物 - 药物，药物 - 基因和药物条件相互作用寻找个性化多酚疗法的方法
5. Part I. Design, synthesis and biological evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. Part II. Development of novel taxoid-based drug conjugates and theranostic imaging agents towards tumor-targeted chemotherapy. [D] . Park, Bora. 2014

机译：第一部分：针对FtsZ作为抗结核药的新型2,5,6-三取代苯并咪唑的设计，合成和生物学评估。第二部分新型基于紫杉醇的药物结合物和治疗诊断剂在肿瘤靶向化疗中的应用。
6. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy. [O] . K. R. Harrap, B. T. Hill 1969

机译：烷基化剂作用的选择性和耐药性。 I.化疗后吉田腹水肉瘤敏感和耐药菌株中发生的生化变化。
7. New drugs for asthma therapy (agents and actions supplements, vol 34) Edited by G.P. Anderson, I.D. Chapman and J. Morley; Birckhauser-Verlag; Basel/Boston/Berlin, 1991; x + 548 pages, Sw.Fr.148.00 [O] . Whelan C.J. 1992

机译：哮喘治疗新药（Agents and ActionSupplements，第34卷）由G.P.安德森（I.D.）查普曼和J.莫利； Birckhauser-Verlag;巴塞尔/波士顿/柏林，1991年； x + 548页，瑞士法郎148.00

New drugs for asthma therapy (agents and actions supplements, vol 34)

著录项

相似文献

相关主题

期刊订阅